Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37
Closed -$2.18K 1104
2025
Q1
$2.18K Hold
37
﹤0.01% 966
2024
Q4
$2.56K Hold
37
﹤0.01% 1187
2024
Q3
$2.77K Hold
37
﹤0.01% 974
2024
Q2
$2.5K Hold
37
﹤0.01% 920
2024
Q1
$2.96K Buy
37
+4
+12% +$357 ﹤0.01% 892
2023
Q4
$3.69K Hold
33
﹤0.01% 829
2023
Q3
$3.53K Buy
33
+2
+6% +$230 ﹤0.01% 828
2023
Q2
$4.23K Hold
31
﹤0.01% 806
2023
Q1
$3.19K Sell
31
-7
-18% -$677 ﹤0.01% 804
2022
Q4
$3.39K Buy
+38
New +$3.15K ﹤0.01% 806

Other funds holding CNMD

Colonial Trust's CNMD Position: Q2 2025 in Review

Colonial Trust sold out of CONMED (CNMD) in Q2 2025, closing a stake of 37 shares — an estimated $2.18K sold.

Colonial Trust first reported a position in CNMD in Q4 2022 and held it in 10 quarters. The position peaked at $4.23K in Q2 2023. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Colonial Trust reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Colonial Trust sold 37 CONMED shares in Q2 2025, an estimated $2.18K.
  • Colonial Trust first reported a position in CONMED in Q4 2022 and held it in 10 quarters.
  • Colonial Trust's CONMED position peaked at $4.23K in Q2 2023.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Colonial Trust's 13F filing for Q2 2025, filed 13 Aug 2025.